Keryx drug improves phosphorus, iron in kidney patients: trial

(Reuters) - A pivotal trial of Keryx Biopharmaceuticals Inc's experimental drug Zerenex showed that it improved levels of serum phosphorus and iron in patients on kidney dialysis, according to results published on Thursday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news